Literature DB >> 7862728

Ibogaine modulates cocaine responses which are altered due to environmental habituation: in vivo microvoltammetric and behavioral studies.

P A Broderick1, F T Phelan, F Eng, R T Wechsler.   

Abstract

Ibogaine, a serotonergic (5-HTergic) indole alkaloid, was studied for cocaine modulatory effects on four parameters of behavior by computerized infrared photocell beam detection. The behavioral parameters were: a) locomotor activity (ambulations), b) rearing, c) stereotypy (fine movements, primarily grooming), and d) agoraphobia [(thigmotaxis) a natural tendency to avoid the center of the behavioral chamber]. With each behavioral data point, dopamine (DA) release, and serotonin (5-HT) release were detected within seconds in nucleus accumbens (NAcc) of the same behaving male Sprague-Dawley rats, using in vivo electrochemistry (voltammetry). Ibogaine was administered (40 mg/kg IP) for 4 consecutive days. Importantly, the DAergic and the 5-HTergic responses to (SC) cocaine and two behavioral responses, ambulations and central ambulations, were reduced in intensity due to extended time spent in the novel behavioral chamber (habituated). Rearing and fine movement patterns were not habituated. The results show that ibogaine downmodulated the (SC) cocaine-induced increase in NAcc DA release (p < 0.0001) and potentiated the (SC) cocaine-induced decrease in NAcc 5-HT release (p < 0.0001). Concurrently, ibogaine downmodulated cocaine-induced ambulation (p < 0.0001) and central ambulation behavior (p < 0.0001). On the other hand, the behavioral parameters that did not exhibit habituation, i.e., rearing behavior and fine movement behavior, were not downmodulated by ibogaine (p < 0.1558) (p < 0.3763), respectively. Furthermore, ibogaine itself did not significantly alter NAcc DA release over the 2-h period studied (p < 0.9113) although individual time points were significantly affected bidirectionally. Concurrently ibogaine significantly increased 5-HT release (p < 0.0155). Behaviorally, ibogaine appears to be a weak psychostimulant. The data show a critical modulatory role for 5-HT in ibogaine-cocaine interactions. Also elucidated as critical is the efficacy of ibogaine when the response to (SC) cocaine is decreased due to the habituation of the animals to their environment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7862728      PMCID: PMC7157928          DOI: 10.1016/0091-3057(94)90092-2

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  56 in total

1.  Evidence for an antagonistic action of tabernanthine on hypoxia-induced changes in brain serotonin levels.

Authors:  E Mocaër-Cretet; M Prioux-Guyonneau; F Redjimi; Y Cohen; C Jacquot
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-07       Impact factor: 3.000

2.  Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies.

Authors:  D C Deecher; M Teitler; D M Soderlund; W G Bornmann; M E Kuehne; S D Glick
Journal:  Brain Res       Date:  1992-02-07       Impact factor: 3.252

3.  The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.

Authors:  M D Tricklebank; C Forler; J R Fozard
Journal:  Eur J Pharmacol       Date:  1984-11-13       Impact factor: 4.432

4.  Effects and aftereffects of ibogaine on morphine self-administration in rats.

Authors:  S D Glick; K Rossman; S Steindorf; I M Maisonneuve; J N Carlson
Journal:  Eur J Pharmacol       Date:  1991-04-03       Impact factor: 4.432

5.  Characterizing stearate probes in vitro for the electrochemical detection of dopamine and serotonin.

Authors:  P A Broderick
Journal:  Brain Res       Date:  1989-08-21       Impact factor: 3.252

6.  Effect of ibogaine on naloxone-precipitated withdrawal syndrome in chronic morphine-dependent rats.

Authors:  E D Dzoljic; C D Kaplan; M R Dzoljic
Journal:  Arch Int Pharmacodyn Ther       Date:  1988 Jul-Aug

7.  Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in rats.

Authors:  I M Maisonneuve; K L Rossman; R W Keller; S D Glick
Journal:  Brain Res       Date:  1992-03-13       Impact factor: 3.252

8.  Cytotoxicity of modified indole alkaloids.

Authors:  D G Kingston; S M Sami
Journal:  J Pharm Sci       Date:  1979-11       Impact factor: 3.534

9.  Real time detection of acute (IP) cocaine-enhanced dopamine and serotonin release in ventrolateral nucleus accumbens of the behaving Norway rat.

Authors:  P A Broderick; E P Kornak; F Eng; R Wechsler
Journal:  Pharmacol Biochem Behav       Date:  1993-11       Impact factor: 3.533

10.  In vivo voltammetric studies on release mechanisms for cocaine with gamma-butyrolactone.

Authors:  P A Broderick
Journal:  Pharmacol Biochem Behav       Date:  1991-12       Impact factor: 3.533

View more
  2 in total

1.  Neuropharmacological characterization of local ibogaine effects on dopamine release.

Authors:  M S Reid; K Hsu; K H Souza; P A Broderick; S P Berger
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

2.  Pharmacological screen for activities of 12-hydroxyibogamine: a primary metabolite of the indole alkaloid ibogaine.

Authors:  J K Staley; Q Ouyang; J Pablo; W L Hearn; D D Flynn; R B Rothman; K C Rice; D C Mash
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.